Have your own idea? Try our Stock Screener
Spanish (IBEX) Pharma Industry Analysis
UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies5
- 7D1.1%
- 3M20.7%
- 1Y35.8%
- YTD6.0%
Almirall is up 2.1%, leading the way for the Pharma industry, which has gained 1.1%. This means that the industry has gained 36% over the past year. Looking forward, earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Spanish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | €8.4b | €2.8b | €273.4m | 33.1x | 30.6x | 3x |
| Tue, 06 Jan 2026 | €8.0b | €2.8b | €273.4m | 37.9x | 29.3x | 2.9x |
| Thu, 04 Dec 2025 | €7.5b | €2.8b | €273.4m | 37x | 27.6x | 2.7x |
| Sat, 01 Nov 2025 | €7.4b | €2.7b | €265.3m | 30.4x | 28x | 2.8x |
| Mon, 29 Sep 2025 | €6.8b | €2.7b | €265.3m | 28.7x | 25.7x | 2.5x |
| Wed, 27 Aug 2025 | €6.8b | €2.7b | €265.3m | 29.8x | 25.8x | 2.6x |
| Fri, 25 Jul 2025 | €6.9b | €2.7b | €284.5m | 21.6x | 24.3x | 2.6x |
| Sun, 22 Jun 2025 | €6.8b | €2.7b | €284.5m | 21.4x | 23.8x | 2.5x |
| Tue, 20 May 2025 | €6.4b | €2.7b | €284.4m | 23.7x | 22.4x | 2.3x |
| Thu, 17 Apr 2025 | €6.0b | €2.7b | €267.7m | 19.7x | 22.3x | 2.2x |
| Sat, 15 Mar 2025 | €6.1b | €2.7b | €267.7m | 19.7x | 22.9x | 2.3x |
| Mon, 10 Feb 2025 | €6.1b | €2.7b | €226.1m | 17.2x | 27.2x | 2.3x |
| Wed, 08 Jan 2025 | €6.3b | €2.7b | €226.1m | 19.6x | 27.9x | 2.4x |
| Fri, 06 Dec 2024 | €6.4b | €2.7b | €226.1m | 19.8x | 28.3x | 2.4x |
| Sun, 03 Nov 2024 | €7.4b | €2.5b | €220.1m | 24.4x | 33.5x | 2.9x |
| Tue, 01 Oct 2024 | €6.9b | €2.5b | €219.5m | 23.5x | 31.5x | 2.7x |
| Thu, 29 Aug 2024 | €7.2b | €2.5b | €219.5m | 23.9x | 32.9x | 2.8x |
| Sat, 27 Jul 2024 | €7.9b | €2.5b | €206.3m | 25x | 38.5x | 3.2x |
| Mon, 24 Jun 2024 | €7.6b | €2.5b | €202.7m | 25.5x | 37.7x | 3.1x |
| Wed, 22 May 2024 | €7.9b | €2.6b | €193.1m | 24.4x | 41.1x | 3.1x |
| Fri, 19 Apr 2024 | €7.0b | €2.6b | €223.6m | 22x | 31.5x | 2.7x |
| Sun, 17 Mar 2024 | €6.8b | €2.6b | €223.6m | 21.1x | 30.5x | 2.6x |
| Tue, 13 Feb 2024 | €6.6b | €2.6b | €295.8m | 17x | 22.2x | 2.5x |
| Thu, 11 Jan 2024 | €6.3b | €2.6b | €296.4m | 16.3x | 21.3x | 2.4x |
| Sat, 09 Dec 2023 | €6.0b | €2.6b | €296.4m | 15.6x | 20.4x | 2.3x |
| Mon, 06 Nov 2023 | €5.5b | €2.5b | €276.0m | 13.7x | 19.8x | 2.2x |
| Wed, 04 Oct 2023 | €5.9b | €2.5b | €274.5m | 14.6x | 21.5x | 2.4x |
| Fri, 01 Sep 2023 | €6.0b | €2.5b | €274.5m | 15.1x | 21.8x | 2.4x |
| Sun, 30 Jul 2023 | €5.3b | €2.5b | €274.5m | 12.4x | 19.4x | 2.2x |
| Tue, 27 Jun 2023 | €4.8b | €2.4b | €284.3m | 11.3x | 16.8x | 2x |
| Thu, 25 May 2023 | €5.1b | €2.4b | €284.3m | 11.9x | 17.9x | 2.1x |
| Sat, 22 Apr 2023 | €5.0b | €2.4b | €301.6m | 17.9x | 16.7x | 2.1x |
| Mon, 20 Mar 2023 | €4.9b | €2.4b | €301.6m | 17.6x | 16.2x | 2x |
| Wed, 15 Feb 2023 | €5.1b | €2.3b | €275.8m | 30.1x | 18.6x | 2.2x |
Price to Earnings Ratio
18.6x
Current Industry PE
- Investors are optimistic on the Spanish Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 30.6x which is higher than its 3-year average PE of 25.7x.
- The 3-year average PS ratio of 2.5x is lower than the industry's current PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.8% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 0.42% | |
| Healthcare | 0.66% | |
| Pharma | 1.09% | |
| Pharma | 1.09% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALM Almirall | €12.88 | 2.1% +€55.8m | 42.3% | PE65.8x | |
| ROVI Laboratorios Farmaceuticos Rovi | €72.85 | 1.3% +€48.6m | 31.3% | PE30.8x |
